NCT06062056

Brief Summary

The goal of this clinical trial is to test whether modified behavioral health services, integrating motivational interviewing, will reduce vaccine hesitancy and increase uptake for the COVID-19 and influenza vaccines among Latinx adults with mental illness.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,698

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 2, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

October 2, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

September 15, 2025

Status Verified

September 1, 2025

Enrollment Period

1.6 years

First QC Date

August 3, 2023

Last Update Submit

September 9, 2025

Conditions

Keywords

COVID-19InfluenzaLatinxBehavioral healthMotivational interviewing

Outcome Measures

Primary Outcomes (2)

  • Received COVID-19 vaccine/booster following an eligible behavioral health visit

    Binary indicator extracted from EHR

    Within 6 weeks of an eligible behavioral health visit

  • Received influenza vaccine following an eligible behavioral health visit

    Binary indicator extracted from EHR

    Within 6 weeks of an eligible behavioral health visit

Secondary Outcomes (3)

  • Survey measure of vaccine hesitancy

    Completed within one week of an eligible behavioral health visit

  • Survey measure of provider trust

    Completed within one week of an eligible behavioral health visit

  • Survey measure of vaccination intention

    Completed within one week of an eligible behavioral health visit

Other Outcomes (3)

  • COVID-19 vaccine series initiation (at least one dose of the vaccine)

    12 month intervals over a total of 48 months

  • Up to date with COVID-19 vaccination (consistent with CDC guidelines)

    12 month intervals over a total of 48 months

  • Up to date with influenza vaccine; received vaccine for current season (consistent with CDC guidelines)

    12 month intervals over a total of 48 months

Study Arms (2)

Intervention

EXPERIMENTAL

Behavioral health clinicians will use motivational interviewing with eligible patients to address vaccine hesitancy

Other: EHR alertBehavioral: Motivational InterviewingBehavioral: Warm hand off to nurse

Control

NO INTERVENTION

Control sites will adhere to standard practice in behavioral health sessions (i.e., no discussions about vaccination)

Interventions

An EHR alert will be fired if a behavioral health patient is missing a COVID-19 or influenza vaccine.

Intervention

In response to the alert and using support tools in the EHR, the behavioral health clinician will integrate motivational interviewing into the counseling session to discuss vaccine hesitancy (if it is deemed appropriate based on patient needs and clinical judgment).

Intervention

For patients interested in vaccination following motivational interviewing, the behavioral health clinician will do a warm hand off to a nurse for vaccination

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years and older
  • Identifies as Latinx or speaks Spanish
  • Completed an eligible behavioral health (BH) visit between the start and end dates of the intervention period.
  • Patient is missing a COVID-19 vaccine/booster or the influenza vaccine at the beginning of their behavioral health visit (i.e., they are not fully up to date with their COVID-19 and influenza vaccines)

You may not qualify if:

  • \- NA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

South End Community Health Center

Boston, Massachusetts, 02118, United States

Location

East Boston Neighborhood Health Center

Boston, Massachusetts, 02128, United States

Location

Related Publications (1)

  • Scrivano RM, van de Water BJ, Rueras N, Alfonso J, McManama O'Brien KH, Soto X, Caumeran VJS, Campos BM, Mancusi M, Diehl B, Southwick E, Moreno E, Bora C, Armbruster S, Abuelezam NN, Calvo R, Haneuse S, Davison KK. Motivational Interviewing for Vaccine Uptake in Latinx Adults (MI Vacuna): Study protocol for a pragmatic multiple-period cluster-randomized crossover trial. Contemp Clin Trials. 2025 Aug;155:107987. doi: 10.1016/j.cct.2025.107987. Epub 2025 Jun 14.

    PMID: 40523466BACKGROUND

Related Links

MeSH Terms

Conditions

Vaccination HesitancyCOVID-19Influenza, Human

Interventions

Motivational Interviewing

Condition Hierarchy (Ancestors)

Vaccination RefusalTreatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehaviorPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesOrthomyxoviridae Infections

Intervention Hierarchy (Ancestors)

Directive CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Kirsten Davison, PhD

    Boston College

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: A pragmatic multiple-period, cluster-randomized crossover design will be used.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2023

First Posted

October 2, 2023

Study Start

October 2, 2023

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

September 15, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

We submitted our application for review prior to the implementation of the new data sharing guidelines (January 25, 2023)

Locations